NFKB1 and glioma: Administration of TLR4 ligand LPS to glioma cells not only induced the activation of NF-κB pathway but also the MyD88-dependent Notch pathways, which suppressed the expression of glioma differentiation marker glial fibrillary acidic protein, leading to reversed glioma differentiation and tumor progression [87].